Hypouricemic effect of statins: another pleiotropic benefit?
López-Cuenca
Angel
A
Roldán
Vanessa
V
Marín
Francisco
F
D000069059:Atorvastatin; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism; D001026:Coronary Artery Bypass / Q000009:adverse effects; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D033461:Hyperuricemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D008055:Lipids / Q000097:blood; D011758:Pyrroles / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome; D014527:Uric Acid / Q000097:blood*
D015415:Biomarkers; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D011758:Pyrroles; D014527:Uric Acid; D002097:C-Reactive Protein; D000069059:Atorvastatin